Should vitamin K be supplemented instead of antagonised in patients with idiopathic pulmonary fibrosis?

References

• Raghu G, Rochwerg B, Zhang Y, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192(2):e3–19.
   PubMed Web of Science ®Google Scholar
• Raghu G, Amatto VC, Behr J, et al. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review. Eur Respir J. 2015;46(4):1113–1130.
   PubMed Web of Science ®Google Scholar
• Garcia AA, Reitsma PH. VKORC1 and the vitamin K cycle. Vitam Horm. 2008;78:23–33.
   PubMed Web of Science ®Google Scholar
• Berkner KL. Vitamin K-dependent carboxylation. Vitam Horm. 2008;78:131–156.
   PubMed Web of Science ®Google Scholar
• Wygrecka M, Markart P, Ruppert C, et al. Cellular origin of pro-coagulant and (anti)-fibrinolytic factors in bleomycin-injured lungs. Eur Respir J. 2007;29(6):1105–1114.
   PubMed Web of Science ®Google Scholar
• Kotani I, Sato A, Hayakawa H, et al. Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis. Thromb Res. 1995;77(6):493–504.
   PubMed Web of Science ®Google Scholar
• Fujii M, Hayakawa H, Urano T, et al. Relevance of tissue factor and tissue factor pathway inhibitor for hypercoagulable state in the lungs of patients with idiopathic pulmonary fibrosis. Thromb Res. 2000;99(2):111–117.
   PubMed Web of Science ®Google Scholar
• Navaratnam V, Fogarty AW, McKeever T, et al. Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case-control study. Thorax. 2014;69(3):207–215.
   PubMed Web of Science ®Google Scholar
• Hubbard RB, Smith C, Le Jeune I, et al. The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study. Am J Respir Crit Care Med. 2008;178(12):1257–1261.
   PubMed Web of Science ®Google Scholar
• Sode BF, Dahl M, Nielsen SF, et al. Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study. Am J Respir Crit Care Med. 2010;181(10):1085–1092.
   PubMed Web of Science ®Google Scholar
• Sprunger DB, Olson AL, Huie TJ, et al. Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease. Eur Respir J. 2012;39(1):125–132.
   PubMed Web of Science ®Google Scholar
• Noth I, Anstrom KJ, Calvert SB, et al. A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2012;186(1):88–95.
   PubMed Web of Science ®Google Scholar
• Tomassetti S, Ruy JH, Gurioli C, et al. The effect of anticoagulant therapy for idiopathic pulmonary fibrosis in real life practice. Sarcoidosis Vasc Diffuse Lung Dis. 2013;30(2):121–127.
   PubMed Web of Science ®Google Scholar
• Kreuter M, Wijsenbeek MS, Vasakova M, et al. Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis. Eur Respir J. 2016;47(6):1776–1784.
   PubMed Web of Science ®Google Scholar
• Alagha K, Secq V, Pahus L, et al. We should prohibit warfarin in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2015;191(8):958–960.
   PubMed Web of Science ®Google Scholar
• Furie B, Furie BC. Molecular basis of vitamin K-dependent gamma-carboxylation. Blood. 1990;75(9):1753–1762.
   PubMed Web of Science ®Google Scholar
• Vermeer C. Vitamin K: the effect on health beyond coagulation – an overview. Food Nutr Res. 2012;56:10.3402.
   Web of Science ®Google Scholar
• Shearer MJ, Newman P. Metabolism and cell biology of vitamin K. Thromb Haemost. 2008;100(4):530–547.
   PubMed Web of Science ®Google Scholar
• Beulens JW, Booth SL, van den Heuvel EG, et al. The role of menaquinones (vitamin K₂) in human health. Br J Nutr. 2013;110(8):1357–1368.
   PubMed Web of Science ®Google Scholar
• Luo G, Ducy P, McKee MD, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997;386(6620):78–81.
   PubMed Web of Science ®Google Scholar
• Basalyga DM, Simionescu DT, Xiong W, et al. Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation. 2004;110(22):3480–3487.
   PubMed Web of Science ®Google Scholar
• Price PA, Toroian D, Lim JE. Mineralization by inhibitor exclusion: the calcification of collagen with fetuin. J Biol Chem. 2009;284(25):17092–17101.
   PubMed Web of Science ®Google Scholar
• Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013;19(4):217–226.
   PubMed Web of Science ®Google Scholar
• Price PA, Buckley JR, Williamson MK. The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin D-induced calcification of arteries, cartilage, lungs and kidneys in rats. J Nutr. 2001;131(11):2910–2915.
   PubMed Web of Science ®Google Scholar
• Fraser JD, Price PA. Lung, heart, and kidney express high levels of mRNA for the vitamin K-dependent matrix Gla protein. Implications for the possible functions of matrix Gla protein and for the tissue distribution of the gamma-carboxylase. J Biol Chem. 1988;263(23):11033–11036.
   PubMed Web of Science ®Google Scholar
• Hardie WD, Korfhagen TR, Sartor MA, et al. Genomic profile of matrix and vasculature remodeling in TGF-alpha induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 2007;37(3):309–321.
   PubMed Web of Science ®Google Scholar
• Booth AJ, Hadley R, Cornett AM, et al. Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation. Am J Respir Crit Care Med. 2012;186(9):866–876.
   PubMed Web of Science ®Google Scholar
• Chatrou ML, Cleutjens JP, van der Vusse GJ, et al. Intra-section analysis of human coronary arteries reveals a potential role for micro-calcifications in macrophage recruitment in the early stage of atherosclerosis. PLoS One. 2015;10(11):e0142335.
   PubMed Web of Science ®Google Scholar
• Demer LL, Tintut Y. Inflammatory, metabolic, and genetic mechanisms of vascular calcification. Arterioscler Thromb Vasc Biol. 2014;34(4):715–723.
   PubMed Web of Science ®Google Scholar
• Egashira R, Jacob J, Kokosi MA, et al. Diffuse pulmonary ossification in fibrosing interstitial lung diseases: prevalence and associations. Radiology. 2017;284(1):255–263.
   PubMed Web of Science ®Google Scholar
• Cranenburg EC, Koos R, Schurgers LJ, et al. Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thromb Haemost. 2010;104(4):811–822.
   PubMed Web of Science ®Google Scholar
• Weijs B, Blaauw Y, Rennenberg RJ, et al. Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients. Eur Heart J. 2011;32(20):2555–2562.
   PubMed Web of Science ®Google Scholar
• Rennenberg RJ, Van Varik BJ, Schurgers LJ, et al. Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans. Blood. 2010;115(24):5121–5123.
   PubMed Web of Science ®Google Scholar
• Lemke G. Biology of the TAM receptors. Cold Spring Harb Perspect Biol. 2013;5(11):a009076.
   PubMed Web of Science ®Google Scholar
• Urawa M, Kobayashi T, D’Alessandro-Gabazza CN, et al. Protein S is protective in pulmonary fibrosis. J Thromb Haemost. 2016;14(8):1588–1599.
   PubMed Web of Science ®Google Scholar
• Bárcena C, Stefanovic M, Tutusaus A, et al. Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation. J Hepatol. 2015;63(3):670–678.
   PubMed Web of Science ®Google Scholar
• Zhao YF, Xu DC, Zhu GF, et al. Growth arrest-specific 6 exacerbates pressure overload-induced cardiac hypertrophy. Hypertension. 2016;67(1):118–129.
   PubMed Web of Science ®Google Scholar
• Shibata T, Ismailoglu UB, Kittan NA, et al. Role of growth arrest-specific gene 6 in the development of fungal allergic airway disease in mice. Am J Respir Cell Mol Biol. 2014;51(5):615–625.
   PubMed Web of Science ®Google Scholar
• Giangola MD, Yang WL, Rajayer SR, et al. Growth arrest-specific protein 6 attenuates neutrophil migration and acute lung injury in sepsis. Shock. 2013;40(6):485–491.
   PubMed Web of Science ®Google Scholar
• Bellido-Martín L, Pg DF. Vitamin K-dependent actions of Gas6. Vitam Horm. 2008;78:185–209.
   PubMed Web of Science ®Google Scholar
• Fusaro M, Gallieni M, Rizzo MA, et al. Vitamin K plasma levels determination in human health. Clin Chem Lab Med. 2017;55(6):789–799.
   PubMed Web of Science ®Google Scholar
• Shea MK, Booth SL. Concepts and controversies in evaluating vitamin K status in population-based studies. Nutrients. 2016;8(1). DOI:10.3390/nu8010008
   PubMed Web of Science ®Google Scholar
• Theuwissen E, Teunissen KJ, Spronk HM, et al. Effect of low-dose supplements of menaquinone-7 (vitamin K2) on the stability of oral anticoagulant treatment: dose-response relationship in healthy volunteers. J Thromb Haemost. 2013;11(6):1085–1092.
   PubMed Web of Science ®Google Scholar
• Nathan SD, Basavaraj A, Reichner C, et al. Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis. Respir Med. 2010;104(7):1035–1041.
   PubMed Web of Science ®Google Scholar
• Nathan SD, Weir N, Shlobin OA, et al. The value of computed tomography scanning for the detection of coronary artery disease in patients with idiopathic pulmonary fibrosis. Respirology. 2011;16(3):481–486.
   PubMed Web of Science ®Google Scholar
• Kim WY, Mok Y, Kim GW, et al. Association between idiopathic pulmonary fibrosis and coronary artery disease: a case-control study and cohort analysis. Sarcoidosis Vasc Diffuse Lung Dis. 2015;31(4):289–296.
   PubMed Web of Science ®Google Scholar
• Beulens JW, Bots ML, Atsma F, et al. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis. 2009;203(2):489–493.
   PubMed Web of Science ®Google Scholar
• Hubbard R, Venn A, Lewis S, et al. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med. 2000;161(1):5–8.
   PubMed Web of Science ®Google Scholar
• Nimptsch K, Rohrmann S, Kaaks R, et al. Dietary vitamin K intake in relation to cancer incidence and mortality: results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). Am J Clin Nutr. 2010;91(5):1348–1358.
   PubMed Web of Science ®Google Scholar
• Molitor H, Robinson HJ. Oral and parenteral toxicity of vitamin K1, phthicol and 2-methyl-1,4-naphthoquinone. Proc Soc Exp Biol Med. 1940;43:125–128.
   Google Scholar
• Theuwissen E, Cranenburg EC, Knapen MH, et al. Low-dose menaquinone-7 supplementation improved extra-hepatic vitamin K status, but had no effect on thrombin generation in healthy subjects. Br J Nutr. 2012;108(9):1652–1657.
   PubMed Web of Science ®Google Scholar
• José RJ, Williams AE, Chambers RC. Proteinase-activated receptors in fibroproliferative lung disease. Thorax. 2014;69(2):190–192.
   PubMed Web of Science ®Google Scholar
• Spronk HM, De Jong AM, Crijns HJ, et al. Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants. Cardiovasc Res. 2014;101(3):344–351.
   PubMed Web of Science ®Google Scholar
• Schurgers LJ, Spronk HM. Differential cellular effects of old and new oral anticoagulants: consequences to the genesis and progression of atherosclerosis. Thromb Haemost. 2014;112(5):909–917.
   PubMed Web of Science ®Google Scholar
• Bogatkevich GS, Ludwicka-Bradley A, Silver RM. Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts. Arthritis Rheum. 2009;60(11):3455–3464.
   PubMed Web of Science ®Google Scholar
• Bogatkevich GS, Ludwicka-Bradley A, Nietert PJ, et al. Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease. Arthritis Rheum. 2011;63(5):1416–1425.
   PubMed Web of Science ®Google Scholar
• Mayer O Jr, Seidlerová J, Bruthans J, et al. Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease. Atherosclerosis. 2014;235(1):162–168.
   PubMed Web of Science ®Google Scholar
• Schlieper G, Westenfeld R, Krüger T, et al. Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. J Am Soc Nephrol. 2011;22(2):387–395.
   PubMed Web of Science ®Google Scholar